Bristol Myers Squibb (BMY) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at ...

Princeton, New Jersey-based Bristol-Myers Squibb Company (BMY) discovers, develops, licenses, manufactures, markets, ...

Bristol-Myers Squibb Company remains a solid, cash-generative blue-chip stock, with expected slow growth & patience. Learn ...

CHONGQING, CHINA - APRIL 20: In this photo illustration, the Bristol Myers Squibb logo is displayed on a smartphone screen, with the company's signature purple branding in the background, on April 20, ...

Bristol Myers Squibb (BMY) closed at $44.54 in the latest trading session, marking a +2.18% move from the prior day.

Bristol-Myers Squibb Company may be undervalued despite strong earnings, M&A, and growth prospects. Click for my BMY earnings ...

The headline numbers for Bristol Myers (BMY) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street ...

Analysts are estimating that Bristol-Myers Squibb will report an earnings per share (EPS) of $1.51. The market awaits Bristol ...

From a valuation standpoint, BMY is trading at a discount to the large-cap pharma industry. Going by the price/earnings ratio ...

Investors in Bristol Myers Squibb Co. (Symbol: BMY) saw new options begin trading today, for the July 25th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BMY ...

Investors in Bristol Myers Squibb Co. (Symbol: BMY) saw new options begin trading today, for the May 30th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BMY ...